SCHEMBL5925075

SCHEMBL5925075

CC(C)[CH]c1ccc(-c2cc(C(=O)O)ccc2Cl)nc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LDHA P00338 3/20 0.47
▸ LDHB P07195 1/20 0.47
▸ CSNK2A2 P19784 3/20 0.41
▸ CSNK2B P67870 3/20 0.41
▸ CSNK2A1 P68400 3/20 0.41
▸ CSNK2A3 Q8NEV1 3/20 0.41
▸ P4HA1 P13674 2/20 0.41
▸ P4HTM Q9NXG6 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ SRD5A2 P31213 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ KMO O15229 1/20 0.37
▸ MAPT P10636 3/20 0.37
▸ THRB P10828 3/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ APEX1 P27695 1/20 0.37
▸ RECQL P46063 1/20 0.37
▸ TTR P02766 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5925079 0.79 LDHA (0.45) LDHALDHBP4HA1P4HTMTSHR
SCHEMBL5924626 0.75 IDO1 (0.41) TSHRALDH1A1POLBKMT2AL3MBTL1
SCHEMBL13117407 0.71 KDM4C (0.59) LDHALDHBTSHRKMOKDM4E
SCHEMBL6252126 0.70 P4HA1 (0.61) LDHAP4HA1P4HTMTSHRSMN1; SMN2
SCHEMBL5924725 0.69 TSHR (0.46) LDHALDHBP4HA1P4HTMTSHR
SCHEMBL5924630 0.68 KCNH2 (0.35) SMN1; SMN2HPGD
SCHEMBL1018250 0.68 P4HA1 (0.49) LDHAP4HA1P4HTMSRD5A2KDM4E
SCHEMBL4652654 0.67 LDHA (0.62) LDHAP4HA1P4HTMSMN1; SMN2NPC1
SCHEMBL2554145 0.66 ALDH1A1 (0.56) CSNK2A2CSNK2BCSNK2A1CSNK2A3TSHR
SCHEMBL3340692 0.65 TSHR (0.49) LDHALDHBTSHRSRD5A2KMO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060122184-A1 Cyanomethyl derivatives as cysteine protease inhibitors AXYS PHARMACEUTICALS, INC. (US) 2006-06-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122184-A1 Cyanomethyl derivatives as cysteine protease inhibitors CTSF, CTSB, CTSK LDHA 3136/4885LDHB 1159/4885CSNK2A2 197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback